[HTML][HTML] Crosstalk between cholesterol metabolism and psoriatic inflammation

L Luo, Y Guo, L Chen, J Zhu, C Li - Frontiers in Immunology, 2023 - frontiersin.org
Psoriasis is a chronic autoinflammatory skin disease associated with multiple comorbidities,
with a prevalence ranging from 2 to 3% in the general population. Decades of preclinical …

[HTML][HTML] Lipid disturbances in psoriasis: an update

A Pietrzak, A Michalak-Stoma… - Mediators of …, 2010 - hindawi.com
Psoriasis is a common disease with the population prevalence ranging from 2% to 3%. Its
prevalence in the population is affected by genetic, environmental, viral, infectious …

[HTML][HTML] Aberrations in lipid expression and metabolism in psoriasis

J Nowowiejska, A Baran, I Flisiak - International journal of molecular …, 2021 - mdpi.com
Psoriasis (PSO) is a common skin disease that affects about 1%–3% of the general
population. It is a great medical, social and economic burden since PSO is associated with …

[HTML][HTML] Psoriasis: obesity and fatty acids

M Kunz, JC Simon, A Saalbach - Frontiers in immunology, 2019 - frontiersin.org
Psoriasis is chronic inflammatory skin disease affecting skin, joints, cardiovascular system,
brain, and metabolism. The pathogenesis of psoriasis is mediated by a complex interplay …

Lipoprotein metabolism and inflammation in patients with psoriasis

EJ Armstrong, JG Krueger - The American journal of cardiology, 2016 - Elsevier
Psoriasis is a chronic inflammatory disease associated with a variety of co-morbid
conditions, including cardiovascular disease. Advancements in our understanding of the …

[HTML][HTML] Impact of ROS-dependent lipid metabolism on psoriasis pathophysiology

A Wroński, P Wójcik - International Journal of Molecular Sciences, 2022 - mdpi.com
Psoriasis is the most common autoimmune disease, yet its pathophysiology is not fully
understood. It is now believed that psoriasis is caused by the increased activation of immune …

[HTML][HTML] Bioactive lipid mediator profiles in human psoriasis skin and blood

AV Sorokin, AF Domenichiello, AK Dey, ZX Yuan… - Journal of Investigative …, 2018 - Elsevier
Psoriasis is a chronic immune-mediated disease that represents a unique model for
investigating inflammation at local and systemic levels. Bioactive lipid mediators (LMs) are …

[HTML][HTML] Pathogenic mechanisms shared between psoriasis and cardiovascular disease

R Ghazizadeh, H Shimizu, M Tosa… - International journal of …, 2010 - ncbi.nlm.nih.gov
Psoriasis is associated with an increased risk of cardiovascular disease, a hallmark of which
is atherosclerosis. The objective of this study was to review the pertinent literature and …

Cardiovascular and metabolic diseases comorbid with psoriasis: beyond the skin

M Furue, G Tsuji, T Chiba, T Kadono - Internal medicine, 2017 - jstage.jst.go.jp
A close association of systemic inflammation with cardiovascular diseases and metabolic
syndrome is recently a popular topic in medicine. Psoriasis is a chronic inflammatory skin …

Current understanding of the role of dietary lipids in the pathophysiology of psoriasis

T Honda, K Kabashima - Journal of Dermatological Science, 2019 - Elsevier
Dietary lipids are fundamental nutrients for human health. They are typically composed of
various long-chain fatty acids which include saturated fatty acids (SFAs) and unsaturated …